The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation
Open accessAbstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains one of the best therapeutic options to cure acute leukemia (AL). However, many patients have no human leukocyte antigen (HLA)-matched donor. Recently, we developed a new method for HLA-mismatched/haploidentical transplantation without in vitro T cell depletion (TCD). This method combined granulocyte-colony stimulating factor (G-CSF)-primed bone marrow and peripheral blood with intensive immunosuppression. We analyzed the outcome of 250 consecutive patients with AL who underwent HLA-mismatched/haploidentical transplantation with 1-3 mismatched loci of HLA-A, B, and DR from family donors via our new transplant protocol. Two hundred forty-nine patients achieved sustained, full donor chimerism. The incidence of grade 2-4 acute graft-versus-host disease (aGVHD) was 45.8%, and that of grades 3 and 4 was 13.4%, which was not associated with the extent of HLA disparity. The cumulative incidence of total chronic GVHD (cGVHD) was 53.9% and that of extensive cGVHD was 22.6% in 217 evaluable patients. One hundred forty-one of the 250 patients survived free of disease recurrence at a median of 1092 days (range: 442-2437 days) of follow-up. Seventeen patients received DLI as a treatment for relapse after transplantation and 7 patients achieved leukemia-free survival (LFS). The 3-year probability of LFS for acute myelogenous leukemia (AML) was 70.7% and 55.9%, and for acute lymphoblastic leukemia (ALL) it was 59.7% and 24.8% in standard-risk and high-risk groups, respectively. Lower LFS were associated with diagnosis of acute leukemia in the high-risk group (P= .001, relative risk [RR], 95% confidence interval [CI]: 2.94[1.535-5.631]) and the occurrence of aGVHD of grades 3 and 4 (P= .004). HLA-mismatched/haploidentical HSCT was feasible with unmanipulated blood and bone marrow harvest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1994 Consensus Conference on Acute GVHD Grading.
Przepiorka, D., Weisdorf, D., Martin, P., Hg, K., Beatty, P., Hows, J., & Thomas, E. D. (1995) · PubMed · Cited by 5,037
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Graft-versus-leukemia reactions after bone marrow transplantation
Horowitz, M., Gale, R., Sondel, P., Goldman, J., Kersey, J., Kolb, H., Rimm, A., Ringden, O., Rozman, C., & Speck, B. (1990) · Blood · doi:10.1182/blood.v75.3.555.555 · Cited by 2,774
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391702 · Cited by 1,168
Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings
Beatty, P. G., Clift, R. A., Mickelson, E. M., Nisperos, B. B., Flournoy, N., Martin, P. J., Sanders, J. E., Stewart, P., Buckner, C. D., Storb, R., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509263131301 · Cited by 816
Rowlings, P. A., Przepiorka, D., Klein, J. P., Gale, R. P., Passweg, J. R., Jean Henslee‐Downey, P., Cahn, J., Calderwood, S., Gratwohl, A., Socié, G., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1112925.x · Cited by 685
Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience
Meyers, J. D., Flournoy, N., & Thomas, E. D. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.6.1119 · Cited by 522
Lu, D.-P., Dong, L., Wu, T., Huang, X.-J., Zhang, M.-J., Han, W., Chen, H., Liu, D.-H., Gao, Z.-Y., Chen, Y.-H., et al. (2006) · Blood · doi:10.1182/blood-2005-05-2146 · Cited by 514
Self-citationSzydlo, R., Goldman, J. M., Klein, J. P., Gale, R. P., Ash, R. C., Bach, F. H., Bradley, B. A., Casper, J. T., Flomenberg, N., Gajewski, J. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1767 · Cited by 468
Huang, X.-J., Liu, D.-H., Liu, K.-Y., Xu, L.-P., Chen, H., Han, W., Chen, Y.-H., Wang, J.-Z., Gao, Z.-Y., Zhang, Y.-C., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705445 · Cited by 432
Self-citationRizzieri, D. A., Koh, L. P., Long, G. D., Gasparetto, C., Sullivan, K. M., Horwitz, M., Chute, J., Smith, C., Gong, J. Z., Lagoo, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0953 · Cited by 191
Waller, E. K., Langston, A. A., Lonial, S., Cherry, J., Somani, J., Allen, A. J., Rosenthal, H., & Redei, I. (2003) · Transplantation and Cellular Therapy · doi:10.1016/s1083-8791(03)00127-7 · Cited by 129
Ottinger, H. D., Ferenčík, S., Beelen, D. W., Lindemann, M., Peceny, R., Elmaagacli, A. H., Hüsing, J., & Grosse‐Wilde, H. (2003) · Blood · doi:10.1182/blood-2002-09-2866 · Cited by 109
Benito, A. I., Díaz, M. Á., González‐Vicent, M., Sevilla, J., & Madero, L. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704405 · Cited by 90
Elfenbein, G. J., & Sackstein, R. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.010 · Cited by 71
Chang, Y., Zhao, X., & Huang, X. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.497 · Cited by 68
Self-citationTransplantation of haploidentically mismatched stem cells for the treatment of malignant diseases
Aversa, F., & Martelli, M. F. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0161-7 · Cited by 26
Kodera, Y., Nishida, T., Ichinohe, T., & Saji, H. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.02.001 · Cited by 12
Cited by
Ciurea, S. O., Zhang, M.-J., Bacigalupo, A. A., Bashey, A., Appelbaum, F. R., Aljitawi, O. S., Armand, P., Antin, J. H., Chen, J., Devine, S. M., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639831 · Cited by 662
Who is the best donor for a related HLA haplotype-mismatched transplant?
Wang, Y., Chang, Y.-J., Xu, L.-P., Liu, K.-Y., Liu, D.-H., Zhang, X.-H., Chen, H., Han, W., Chen, Y.-H., Wang, F.-R., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563130 · Cited by 344
Self-citationModern approaches to HLA-haploidentical blood or marrow transplantation
Kanakry, C. G., Fuchs, E. J., & Luznik, L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.128 · Cited by 330
Xu, L., Chen, H., Chen, J., Han, M., Huang, H., Lai, Y., Liu, D., Liu, Q., Liu, T., Jiang, M., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0564-x · Cited by 294
Self-citation
Metadata
- Authors
- Huang, X.-J., Liu, D.-H., Liu, K.-Y., Xu, L.-P., Chen, H., Han, W., Chen, Y.-H., Zhang, X.-H., & Lu, D.-P.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 15
- Issue
- 2
- Pages
- 257-265
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W1982247089
- Cited by
- 294
- References
- 18
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.